Inactive Instrument

News Hi-Tech Pharmacal Co.

Equities

US42840B1017

Summary

Unlock all the news: Be the first to know and act before the market!

Hi Tech Pharmacal : Akorn Completes Acquisition of Hi-Tech Pharmacal	14-04-17	BU
Hi Tech Pharmacal : Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition	14-04-14	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014	14-03-11	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)	14-01-23	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation	13-12-26	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013	13-12-10	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2013	13-09-05	BU
Hi-Tech Pharmacal Co. : HI-TECH PHARMACAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Hi-Tech Pharmacal Co., Inc. Following Announcement of Proposed Sale of Company to Akorn, Inc.	13-08-28	BU
Hi-Tech Pharmacal Co. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hi-Tech Pharmacal Co., Inc. Shareholders	13-08-28	BU
Hi-Tech Pharmacal Co. : Ryan & Maniskas, LLP Announces Investigation of Hi-Tech Pharmacal Co., Inc.	13-08-28	PR
Hi-Tech Pharmacal Co. : Akorn to Acquire Hi-Tech Pharmacal for $640 Million	13-08-27	BU
Hi-Tech Pharmacal Co. : Health Care Products Division of Hi-Tech Pharmacal Receives FDA Warning Letter Related to Labeling Statements on Certain OTC Products	13-07-24	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 9, 2013	13-07-03	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	13-05-09	BU
Hi-Tech Pharmacal Co. : ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEO	13-04-30	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference	13-04-29	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $64.3 Million and EPS of $0.43 for the Third Quarter Ended January 31, 2013	13-03-07	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 7, 2013	13-03-04	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the 2013 RBC Capital Markets' Healthcare Conference	13-02-26	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Oppenheimer 23rd Annual Healthcare Conference	12-12-11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hi-Tech Pharmacal Co.

Equities

US42840B1017

Summary

Filters